A carregar...
Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
BACKGROUND: Metabolic syndrome in patients with schizophrenia is a major health concern. The efficacy and safety of adjunctive rosuvastatin in treating dyslipidemia were controversial. AIMS: To assess the efficacy and safety of adjunctive rosuvastatin for dyslipidemia in patients with schizophrenia....
Na minha lista:
| Publicado no: | Shanghai Arch Psychiatry |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Shanghai Municipal Bureau of Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5925598/ https://ncbi.nlm.nih.gov/pubmed/29719353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11919/j.issn.1002-0829.217156 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|